Explainer · August 4, 2026 · 5 min · By Tariq Mehmood
Silicone Implant Rupture Screening in Los Angeles: What the MRI vs. Ultrasound Guidance Actually Says
Silicone gel implants can rupture without symptoms, which is why the FDA recommends periodic imaging. Here is how the screening schedule works, what each scan can and cannot detect, and what it realistically costs in the LA market.
Silicone gel breast implants are the most commonly chosen device in Los Angeles augmentation practices, and for a mechanical reason patients often do not hear about until after surgery: when a modern cohesive gel implant fails, it frequently fails silently. The gel is thick enough to stay in place, the breast may look and feel unchanged, and the only way to confirm the shell is intact is imaging. That is the entire logic behind the FDA's screening recommendation, and it is worth understanding before you sign a consent form, not after.
What a silent rupture actually is. A saline implant announces its own failure. The shell tears, sterile saltwater is absorbed by the body within days, and the breast visibly deflates. Silicone behaves differently. Current fifth generation cohesive gels hold their shape even when the shell is compromised, so the gel typically stays within the scar capsule the body forms around every implant. This is called an intracapsular rupture, and it produces no pain, no size change, and no lump in most cases. Less commonly, gel migrates beyond the capsule, an extracapsular rupture, which can cause firmness, distortion, or granulomas. Because the intracapsular version dominates and produces no symptoms, physical exams are unreliable. Studies used in the FDA's device reviews found that clinical exam alone misses a substantial share of ruptures that imaging later confirms.
The current screening timeline. In 2020 the FDA updated its labeling guidance for silicone gel implants. The recommendation now reads: first screening at five to six years after implantation, then every two to three years thereafter, for as long as the implants remain in place. This replaced the older advice of an MRI at three years and every two years after, which had poor real world compliance, partly because of cost. The update also formally added high resolution ultrasound as an acceptable screening tool alongside MRI, which changed the economics considerably.
MRI vs. ultrasound: the mechanism of each. MRI without contrast remains the reference standard. It images the silicone signal directly and can show the classic linguine sign, collapsed shell fragments floating within the gel, with sensitivity generally reported around 80 to 90 percent and specificity above 90 percent in published series. Its weaknesses are cost, scan time, and the fact that some patients cannot undergo MRI because of certain implanted metal devices or claustrophobia. High resolution ultrasound works differently. A trained sonographer or physician looks for the stepladder sign, parallel echogenic lines inside the implant that indicate a collapsed shell, and for the snowstorm appearance that suggests extracapsular gel. Ultrasound is fast, radiation free, and inexpensive, but it is strongly operator dependent. In experienced hands its accuracy approaches MRI for intracapsular rupture. In inexperienced hands, it does not. The FDA's compromise position is practical: ultrasound is an acceptable first line screen, and if the result is equivocal or symptoms exist, MRI follows.
What this costs in the Los Angeles market. Screening for an asymptomatic implant is generally considered surveillance of a cosmetic device, so most insurers do not cover it. Cash prices for a non contrast breast MRI at LA area imaging centers commonly run several hundred to over a thousand dollars per study. Dedicated implant ultrasound is typically a fraction of that, often in the low hundreds. Multiply the MRI figure by a screening event every two to three years over the 10 to 20 year realistic lifespan of a device, and the lifetime imaging cost of silicone implants becomes a real line item that saline implants simply do not carry. Surgeons in high volume markets increasingly discuss this at consultation, and patients should ask directly: what will surveillance cost me over 15 years, and who in this practice or nearby performs implant specific ultrasound?
Myth check: rupture rates. Manufacturer core studies submitted to the FDA report rupture rates that rise with device age, roughly in the range of 2 to 12 percent by 8 to 10 years depending on the device, generation, and whether it was a primary or revision case. The often repeated claim that implants must be replaced every ten years regardless of condition is not supported by the labeling. An intact, asymptomatic implant does not have a mandatory expiration date. What it does have is a rising probability of shell failure over time, which is exactly what the screening schedule is designed to catch.
The bottom line. If you have silicone gel implants, put the five to six year mark on a calendar, plan on imaging every two to three years after that, and budget for it as part of the true cost of augmentation. Ultrasound is a reasonable and affordable first look when performed by someone experienced with implants. MRI remains the tiebreaker. A confirmed rupture, even a silent one, is generally an indication for removal or exchange, so the screening is not academic. It determines when the next operation happens.
Related reading: Silicone, Saline, or Gummy Bear: How to Choose an Implant Type.